Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Inhibition of Semaphorin 4D/Plexin-B1 Signal Inhibits the Subchondral Bone Loss in Early-Stage Osteoarthritis of Temporomandibular Joint

Zhaoyichun Zhang
,
Lei Lu
,
Tao Ye
,
Shibin Yu
,
Jing Zhang
,
Mian Zhang
,
Feng He
,
Qian Liu
,
Jianying Feng
,
Hongxu Yang
* ORCID logo
Version 1 : Received: 21 June 2021 / Approved: 23 June 2021 / Online: 23 June 2021 (11:07:01 CEST)

How to cite: Zhang, Z.; Lu, L.; Ye, T.; Yu, S.; Zhang, J.; Zhang, M.; He, F.; Liu, Q.; Feng, J.; Yang, H. Inhibition of Semaphorin 4D/Plexin-B1 Signal Inhibits the Subchondral Bone Loss in Early-Stage Osteoarthritis of Temporomandibular Joint. Preprints 2021, 2021060566. https://doi.org/10.20944/preprints202106.0566.v1 Zhang, Z.; Lu, L.; Ye, T.; Yu, S.; Zhang, J.; Zhang, M.; He, F.; Liu, Q.; Feng, J.; Yang, H. Inhibition of Semaphorin 4D/Plexin-B1 Signal Inhibits the Subchondral Bone Loss in Early-Stage Osteoarthritis of Temporomandibular Joint. Preprints 2021, 2021060566. https://doi.org/10.20944/preprints202106.0566.v1

Abstract

Subchondral bone loss is an important pathological feature of early-stage temporomandibular joint (TMJ) osteoarthritis (OA). Previous studies focused mainly on the bone resorption by osteoclasts in early-stage OA, but the bone formation feature has not drawn enough attention. Sema4D/Plexin-B1 is a pair of molecules expressed by osteoclast/osteoblast, which is capable of inhibiting bone formation by osteoblasts. The present study found that subchondral bone loss in early-stage TMJ OA was accompanied by up-regulated expression of Sema4D in cartilage and subchondral bone and Plexin-B1 in subchondral bone. Reducing Sema4D level could inhibit the subchondral bone loss and cartilage degeneration of early-stage TMJ OA. In vitro, results revealed that Sema4D could reduce the expression of osteocalcin (OCN) and alkaline phosphatase (ALP), and increase the migrating capability of Plexin-B1-positive osteoblasts. Our results revealed that elevated Sema4D expression in early-stage TMJ OA might decrease the bone formation activity of osteoblasts in the subchondral bone by binding to Plexin-B1 expressed by osteoblasts. Inhibiting Sema4D/Plexin-B1 signaling in the early-stage OA holds promise as a strategy for new therapeutic approaches to osteoarthritis.

Keywords

Temporomandibular joint; Osteoarthritis; Semaphorin 4D; Plexin-B1; Osteoblast

Subject

Medicine and Pharmacology, Immunology and Allergy

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF Download Supplementary

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Supplementary Files Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.